The Bio Report

Novartis Deal Validates Perlara’s Approach to Rare Disease Drug Discovery


Listen Later

Perlara is a drug discovery company focused on using model organisms to find treatments for diseases previously believed to be too rare to cure. Recently Perlara entered into a drug discovery and development collaboration with Novartis, a deal that included an equity investment and is seen as validating Perlara’s platform. We spoke to Ethan Perlstein, CEO of Perlara, about the company’s unique approach to drug discovery, why it focuses on the diseases it does, and the significance of its agreement with Novartis.
...more
View all episodesView all episodes
Download on the App Store

The Bio ReportBy Levine Media Group

  • 3.7
  • 3.7
  • 3.7
  • 3.7
  • 3.7

3.7

39 ratings


More shows like The Bio Report

View all
Economist Podcasts by The Economist

Economist Podcasts

4,191 Listeners

WSJ Your Money Briefing by The Wall Street Journal

WSJ Your Money Briefing

1,718 Listeners

We Study Billionaires - The Investor’s Podcast Network by The Investor's Podcast Network

We Study Billionaires - The Investor’s Podcast Network

3,388 Listeners

Masters in Business by Bloomberg

Masters in Business

2,172 Listeners

Bold Names by The Wall Street Journal

Bold Names

1,450 Listeners

The Indicator from Planet Money by NPR

The Indicator from Planet Money

9,514 Listeners

The Readout Loud by STAT

The Readout Loud

324 Listeners

Interesting Times with Ross Douthat by New York Times Opinion

Interesting Times with Ross Douthat

7,161 Listeners

The Journal. by The Wall Street Journal & Spotify Studios

The Journal.

6,096 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

34 Listeners

Dwarkesh Podcast by Dwarkesh Patel

Dwarkesh Podcast

506 Listeners

Hard Fork by The New York Times

Hard Fork

5,471 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

19 Listeners

Ground Truths by Eric Topol

Ground Truths

48 Listeners

Money Stuff: The Podcast by Bloomberg

Money Stuff: The Podcast

386 Listeners